BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsProcurement of Buprenorphine for Therapeutic Units
    Closed contract

    Procurement of Buprenorphine for Therapeutic Units

    Contract value
    €3.5m
    Closed 2 Feb 2026

    This contract involves the supply of buprenorphine medication for the needs of therapeutic units and structures of the National Organization for the Prevention and Treatment of Addictions (EOPAE). The total value of the contract is €3,490,000. Suppliers are invited to provide this essential medicati

    🇬🇷GreecePublished 22 Dec 2025· 8 months agoviaTED
    Contract value
    €3.5m
    Closed 2 Feb 2026
    Tender deadline passed on 2 Feb 2026.

    Decision brief

    4 fields
    • Contract value
      est.€3,490,000
      Euros
    • Tender closed
      2 Feb 2026
      6 months ago
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇬🇷Greece

    Lifecycle

    Closed

    Tender closed on 2 Feb 2026. Awaiting award.

    22 Dec 2025Today2 Feb 2026

    Brief

    This contract involves the supply of buprenorphine medication for the needs of therapeutic units and structures of the National Organization for the Prevention and Treatment of Addictions (EOPAE). The total value of the contract is €3,490,000. Suppliers are invited to provide this essential medication to support addiction treatment services. The deadline for submissions is February 2, 2026. For more details, please visit the contract platform at TED.

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Early Cancer Diagnostic Technologies Development Programme

    Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.

    est.£25,400,000
    Published 1 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Validation of Early Cancer Diagnostic Technologies

    Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.

    est.£25,400,000
    Published 1 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Doxycycline 10-Pack Supply - Market Engagement 2027

    UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.

    £1nominalSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
    Published 21 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Patient Diagnostic and Monitoring Electrodes - Market Engagement Survey

    Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.

    Business Services Organisation Procurement and Logistics
    Published 21 Aug 2026
    Take action
    View on sourceTED

    Original closed notice on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    855641-2025
    NO
    Buyer
    National Organization for Prevention and Treatment of Addictions (NOPAA)
    Sector
    Healthcare & Medical